• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对真实世界数据和小鼠模型的分析表明,吡非尼酮会导致糙皮病。

Analysis of real-world data and a mouse model indicates that pirfenidone causes pellagra.

作者信息

Kuronuma Koji, Susai Natsumi, Kuroita Tomohiro, Yamamoto Hiroki, Yoshioka Takeshi, Kaneko Shuji, Chiba Hirofumi

机构信息

Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Japan.

These authors contributed equally to first authorship.

出版信息

ERJ Open Res. 2022 Oct 24;8(4). doi: 10.1183/23120541.00245-2022. eCollection 2022 Oct.

DOI:10.1183/23120541.00245-2022
PMID:36299372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9589320/
Abstract

BACKGROUND

Pirfenidone (PFD) is widely used in patients with idiopathic pulmonary fibrosis (IPF) and its adverse effects, such as nausea and photosensitivity, are well known. Many patients with IPF have reduced doses or even cessation of PFD because of its side-effects. No solutions have been found for these side-effects because the current mechanistic insights are insufficient.

METHODS

Using the results of real-world data analysis from the US Food and Drug Administration Adverse Events Reporting System, we hypothesised that PFD-related symptoms may be similar to pellagra. Reverse translational experiments using female BALB/c mice were performed to validate and estimate this hypothesis. Niacin and its metabolite responses were compared between patients with IPF treated with PFD and those treated without PFD.

RESULTS

The pellagra hypothesis was translated from real-world data analysis. Pharmacological and comprehensive genetic investigations showed that PFD caused pellagra-related nausea and photosensitivity in a mouse model, which may have been mediated by the actions of nicotinamide methyltransferase (NNMT). Higher NNMT substrate responses were observed in urine from patients and mice with PFD than in those without PFD.

CONCLUSIONS

PFD may cause pellagra or pellagra-like symptoms such as photosensitivity. Further studies are required to investigate whether niacin prevents pellagra-like symptoms caused by PFD in patients with IPF.

摘要

背景

吡非尼酮(PFD)广泛应用于特发性肺纤维化(IPF)患者,其不良反应如恶心和光敏反应广为人知。许多IPF患者因副作用而减少PFD剂量甚至停药。由于目前对其作用机制的认识不足,尚未找到解决这些副作用的方法。

方法

利用美国食品药品监督管理局不良事件报告系统的真实世界数据分析结果,我们推测PFD相关症状可能与糙皮病相似。使用雌性BALB/c小鼠进行反向转化实验以验证和评估这一假设。比较了接受PFD治疗的IPF患者和未接受PFD治疗的患者的烟酸及其代谢物反应。

结果

糙皮病假说源自真实世界数据分析。药理学和综合基因研究表明,PFD在小鼠模型中引起糙皮病相关的恶心和光敏反应,这可能是由烟酰胺甲基转移酶(NNMT)的作用介导的。与未使用PFD的患者和小鼠相比,使用PFD的患者和小鼠尿液中观察到更高的NNMT底物反应。

结论

PFD可能导致糙皮病或类似糙皮病的症状,如光敏反应。需要进一步研究来调查烟酸是否能预防IPF患者中由PFD引起的类似糙皮病的症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/2a01ffdc59f0/00245-2022.06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/4bea2a63d834/00245-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/2b983cd55fd6/00245-2022.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/b53b92d1261b/00245-2022.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/f815bb4abb4c/00245-2022.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/dd09c1d69202/00245-2022.05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/2a01ffdc59f0/00245-2022.06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/4bea2a63d834/00245-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/2b983cd55fd6/00245-2022.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/b53b92d1261b/00245-2022.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/f815bb4abb4c/00245-2022.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/dd09c1d69202/00245-2022.05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6cf/9589320/2a01ffdc59f0/00245-2022.06.jpg

相似文献

1
Analysis of real-world data and a mouse model indicates that pirfenidone causes pellagra.对真实世界数据和小鼠模型的分析表明,吡非尼酮会导致糙皮病。
ERJ Open Res. 2022 Oct 24;8(4). doi: 10.1183/23120541.00245-2022. eCollection 2022 Oct.
2
Protective effect of BB536 against nausea caused by pirfenidone in a mouse model of pellagra.BB536对吡非尼酮在糙皮病小鼠模型中引起的恶心的保护作用。
Biosci Microbiota Food Health. 2023;42(3):195-202. doi: 10.12938/bmfh.2022-042. Epub 2023 Mar 9.
3
[Real-life experience with pirfenidone in idiopathic pulmonary fibrosis].吡非尼酮治疗特发性肺纤维化的真实世界经验
Zhonghua Jie He He Hu Xi Za Zhi. 2018 May 12;41(5):327-332. doi: 10.3760/cma.j.issn.1001-0939.2018.05.004.
4
Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.吡非尼酮可抑制自噬不足时肌成纤维细胞分化和肺纤维化的发展。
Respir Res. 2017 Jun 2;18(1):114. doi: 10.1186/s12931-017-0600-3.
5
The Efficacy and Safety of Long-term Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis.长期使用吡非尼酮治疗特发性肺纤维化患者的疗效和安全性
Intern Med. 2018 Oct 1;57(19):2813-2818. doi: 10.2169/internalmedicine.0559-17. Epub 2018 May 18.
6
A Review of Pirfenidone as an Anti-Fibrotic in Idiopathic Pulmonary Fibrosis and Its Probable Role in Other Diseases.吡非尼酮作为特发性肺纤维化抗纤维化药物的综述及其在其他疾病中的潜在作用
Cureus. 2021 Jan 4;13(1):e12482. doi: 10.7759/cureus.12482.
7
Effect of niacin supplementation on nausea-like behaviour in an isoniazid-induced mouse model of pellagra.烟酸补充剂对异烟肼诱导的糙皮病小鼠模型中类似恶心行为的影响。
Br J Nutr. 2022 Apr 14;127(7):961-971. doi: 10.1017/S0007114521001835. Epub 2021 Jun 3.
8
Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.吡非尼酮治疗的特发性肺纤维化患者用力肺活量早期边缘性下降的预后影响
Respir Investig. 2019 Nov;57(6):552-560. doi: 10.1016/j.resinv.2019.07.003. Epub 2019 Aug 31.
9
Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.吡非尼酮通过防止肝星状细胞激活抑制四氯化碳和白蛋白复合物诱导的啮齿动物肝纤维化。
Clin Exp Pharmacol Physiol. 2009 Oct;36(10):963-8. doi: 10.1111/j.1440-1681.2009.05194.x. Epub 2009 Apr 27.
10
Analysis of the gut microbiome to validate a mouse model of pellagra.分析肠道微生物群以验证糙皮病小鼠模型。
Biosci Microbiota Food Health. 2022;41(2):73-82. doi: 10.12938/bmfh.2021-059. Epub 2022 Jan 24.

引用本文的文献

1
TGF-β inhibitors: the future for prevention and treatment of liver fibrosis?转化生长因子-β抑制剂:预防和治疗肝纤维化的未来希望?
Front Immunol. 2025 Jun 27;16:1583616. doi: 10.3389/fimmu.2025.1583616. eCollection 2025.
2
Protective effect of BB536 against nausea caused by pirfenidone in a mouse model of pellagra.BB536对吡非尼酮在糙皮病小鼠模型中引起的恶心的保护作用。
Biosci Microbiota Food Health. 2023;42(3):195-202. doi: 10.12938/bmfh.2022-042. Epub 2023 Mar 9.

本文引用的文献

1
Role of transient receptor potential vanilloid 4 in therapeutic antifibrotic effects of pirfenidone.瞬时受体电位香草酸亚型4在吡非尼酮治疗性抗纤维化作用中的作用
Am J Physiol Lung Cell Mol Physiol. 2022 Aug 1;323(2):L193-L205. doi: 10.1152/ajplung.00565.2020. Epub 2022 Jul 5.
2
Analysis of the gut microbiome to validate a mouse model of pellagra.分析肠道微生物群以验证糙皮病小鼠模型。
Biosci Microbiota Food Health. 2022;41(2):73-82. doi: 10.12938/bmfh.2021-059. Epub 2022 Jan 24.
3
Drug Repurposing Prediction and Validation From Clinical Big Data for the Effective Treatment of Interstitial Lung Disease.
基于临床大数据的药物重新利用预测与验证以有效治疗间质性肺疾病
Front Pharmacol. 2021 Sep 21;12:635293. doi: 10.3389/fphar.2021.635293. eCollection 2021.
4
Novel approach for attenuation of pirfenidone-induced digestive symptoms: a respirable powder formulation of pirfenidone.一种减轻吡非尼酮引起的消化道症状的新方法:吡非尼酮的可吸入粉末制剂。
Ther Deliv. 2021 Jul;12(7):515-522. doi: 10.4155/tde-2021-0027. Epub 2021 Jun 18.
5
Effect of niacin supplementation on nausea-like behaviour in an isoniazid-induced mouse model of pellagra.烟酸补充剂对异烟肼诱导的糙皮病小鼠模型中类似恶心行为的影响。
Br J Nutr. 2022 Apr 14;127(7):961-971. doi: 10.1017/S0007114521001835. Epub 2021 Jun 3.
6
Pellagra a review exploring causes and mechanisms, including isoniazid-induced pellagra.糙皮病综述:病因与发病机制探讨,包括异烟肼所致糙皮病。
Photodermatol Photoimmunol Photomed. 2021 Mar;37(2):99-104. doi: 10.1111/phpp.12659. Epub 2021 Feb 2.
7
A real-world study of the dosing and tolerability of pirfenidone and its effect on survival in idiopathic pulmonary fibrosis.一项关于吡非尼酮给药剂量、耐受性及其对特发性肺纤维化患者生存率影响的真实世界研究。
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):148-157. doi: 10.36141/svdld.v37i2.8718. Epub 2020 Jun 30.
8
Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions.特发性肺纤维化患者的营养问题:关键问题分析与未来研究方向
Nutrients. 2020 Apr 17;12(4):1131. doi: 10.3390/nu12041131.
9
Drug Repositioning and Target Finding Based on Clinical Evidence.基于临床证据的药物重定位和靶标发现。
Biol Pharm Bull. 2020;43(3):362-365. doi: 10.1248/bpb.b19-00929.
10
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study.吡非尼酮的长期安全性:前瞻性观察性PASSPORT研究结果
ERJ Open Res. 2018 Oct 19;4(4). doi: 10.1183/23120541.00084-2018. eCollection 2018 Oct.